Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies (Q39207594)
Jump to navigation
Jump to search
scientific article published on 15 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies |
scientific article published on 15 February 2013 |
Statements
1 reference
Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies (English)
1 reference
Otto C Boerman
1 reference
Sandra Heskamp
1 reference
Janneke D M Molkenboer-Kuenen
1 reference
Wim J G Oyen
1 reference
Winette T A van der Graaf
1 reference
Hanneke W M van Laarhoven
1 reference
15 February 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference